Price (delayed)
$11.18
Market cap
$165.66M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$17.7
Enterprise value
$9.05M
magenta therapeutics is a biotechnology company harnessing the power of stem cell science to revolutionize stem cell transplantation for patients with immune- and blood-based diseases. by creating a platform focused
There are no recent dividends present for DNTH.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.